Fucoidan inhibits tumor lymphangiogenesis and lymphatic metastasis by suppressing the NF-κB/PI3K/Akt signaling pathway through reduced levels of PROX1 and VEGFR3 in vivo in mice [82]. Here, AKT1 is linked to neoplasm.